Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study

AIMS/HYPOTHESIS: This long-term study was designed to further characterise the retinal safety profile of insulin glargine and human neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes mellitus. METHODS: An open-label, 5 year, randomised (1:1), multicentre, stratified, parallel-...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenstock, J., Fonseca, V., McGill, J. B., Riddle, M., Hallé, J.-P., Hramiak, I., Johnston, P., Davis, M.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723680/
https://www.ncbi.nlm.nih.gov/pubmed/19526210
http://dx.doi.org/10.1007/s00125-009-1415-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723680/
https://www.ncbi.nlm.nih.gov/pubmed/19526210
http://dx.doi.org/10.1007/s00125-009-1415-7

Ejemplares similares